17.01.2021

Valneva: Valneva, an Austrian/French specialty vaccine company focused on prevention against diseases with major unmet needs, today announced an amendment to the terms of its existing debt facility with US-based healthcare investment firms Deerfield Management Company and OrbiMed. Noting the COVID-19 pandemic impact on the travel industry, and following a temporary waiver of the revenue covenant for the second half of 2020, Valneva, Deerfield and OrbiMed have agreed to modify this covenant for 2021 and 2022, replacing the twelve month rolling Euro 115 mn with quarterly minimum revenues representing an annual total of Euro 64 mn in 2021 and an annual total of Euro 103.75 mn in 2022. The parties have also agreed to modify the minimum cash requirement to Euro 50 mn for 2021 and 2023 and to Euro 35 mn for the following years.
Valneva: weekly performance: 31.82%

Do&Co: The extraordinary General Meeting of Shareholders of catering company Do & Co Aktiengesellschaft adopted a resolution to issue convertible bonds with an overall nominal amount of up to Euro 100 mn with subscription and/or conversion rights to up to 1,350,000 no par value bearer shares of the company. 
DO&CO: weekly performance: -5.93%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (15/01/2021)

Bildnachweis

Aktien auf dem Radar:Marinomed Biotech, Bawag, UBM, Warimpex, Lenzing, Andritz, Addiko Bank, Polytec Group, Zumtobel, OMV, SBO, AMS, Rosgix, Verbund, Mayr-Melnhof, Cleen Energy, Gurktaler AG VZ, Wolford, Agrana, Athos Immobilien, Oberbank AG Stamm, EVN.

---